We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-1.06%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$481B
AUM Growth
+$34.6B
Cap. Flow
+$38.1B
Cap. Flow %
7.92%
Top 10 Hldgs %
29.35%
Holding
15,428
New
1,885
Increased
5,794
Reduced
5,768
Closed
1,724

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$1.26B
2
MSFT icon
Microsoft
MSFT
+$633M
3
BABA icon
Alibaba
BABA
+$501M
4
ATVI
Activision Blizzard
ATVI
+$484M
5
AAPL icon
Apple
AAPL
+$456M

Sector Composition

Rank Sector Weight
1 Technology 3.08%
2 Consumer Discretionary 2.25%
3 Financials 2.23%
4 Healthcare 2.22%
5 Industrials 1.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RAIL icon
12626
FreightCar America
RAIL
$240M
$112K ﹤0.01%
24,644
+9,497
+63% +$50.1K
AIOT
12627
PowerFleet Inc
AIOT
$417M
$112K ﹤0.01%
16,729
-42,004
-72% -$291K
QCLS
12628
Q/C Technologies Inc
QCLS
$21.8M
$112K ﹤0.01%
5
-2
-29% -$35.9K
BLNE
12629
PUT
Beeline Holdings
BLNE
$33.2M
$112K ﹤0.01%
+215
New +$142K
ORGS
12630
DELISTED
Orgenesis Inc. Common Stock
ORGS
$112K ﹤0.01%
2,270
-545
-19% -$27.4K
EIGR
12631
PUT
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$112K ﹤0.01%
557
+10
+2% +$2.38K
GTPAW
12632
DELISTED
Gores Technology Partners, Inc. Warrant
GTPAW
$112K ﹤0.01%
100,000
GSS
12633
CALL
DELISTED
Golden Star Resources Ltd.
GSS
$112K ﹤0.01%
47,200
-38,900
-45% -$93.5K
PEI
12634
PUT
DELISTED
Pennsylvania Real Estate Investment Trust
PEI
$112K ﹤0.01%
3,860
-2,613
-40% -$80K
SRTA
12635
Strata Critical Medical Inc
SRTA
$522M
$111K ﹤0.01%
10,692
-175,365
-94% -$1.53M
DARE icon
12636
Dare Bioscience
DARE
$13.9M
$111K ﹤0.01%
+5,551
New +$109K
INDP icon
12637
Indaptus Therapeutics
INDP
$143M
$111K ﹤0.01%
508
+398
+362% +$115K
OSW icon
12638
PUT
OneSpaWorld
OSW
$2.73B
$111K ﹤0.01%
11,100
-46,500
-81% -$458K
GFX.U
12639
DELISTED
Golden Falcon Acquisition Corp. Units, each consisting of one share of Class A Common Stock and one-half of one Warrant
GFX.U
$111K ﹤0.01%
11,059
-603,351
-98% -$6.07M
ANAC.WS
12640
DELISTED
Arctos NorthStar Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
ANAC.WS
$111K ﹤0.01%
150,098
-67,074
-31% -$57.5K
MTCR
12641
DELISTED
Metacrine, Inc. Common Stock
MTCR
$111K ﹤0.01%
32,429
+19,719
+155% +$61.5K
PAQCW
12642
DELISTED
Provident Acquisition Corp. Warrant
PAQCW
$111K ﹤0.01%
+185,438
New +$136K
WARR.WS
12643
DELISTED
Warrior Technologies Acquisition Company Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
WARR.WS
$111K ﹤0.01%
+203,149
New +$137K
NPTN
12644
DELISTED
NEOPHOTONICS CORP
NPTN
$111K ﹤0.01%
12,791
-39,810
-76% -$363K
BTAQU
12645
DELISTED
Burgundy Technology Acquisition Corporation Unit
BTAQU
$111K ﹤0.01%
10,832
+115
+1% +$1.18K
AYTU icon
12646
CALL
AYTU BioPharma
AYTU
$25.5M
$110K ﹤0.01%
1,904
+64
+3% +$4.8K
BVN icon
12647
PUT
Compañía de Minas Buenaventura
BVN
$8.57B
$110K ﹤0.01%
16,300
-53,000
-76% -$409K
ELMD icon
12648
CALL
Electromed
ELMD
$341M
$110K ﹤0.01%
10,200
-1,100
-10% -$13.2K
EVC icon
12649
PUT
Entravision Communication
EVC
$832M
$110K ﹤0.01%
15,500
+300
+2% +$2.02K
FLUX icon
12650
PUT
Flux Power
FLUX
$12.7M
$110K ﹤0.01%
+21,700
New +$183K

Similar funds

Ken Griffin's Q3 2021 Portfolio in Review

As of Q3 2021, Ken Griffin held 15,428 positions worth $481B, up 7.8% from $447B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Ken Griffin deployed $38.1B of net new capital in Q3 2021, opening 1,885 new positions and adding to 5,794 existing holdings. Its largest new stake was Etsy: 948,509 shares worth $197M.

By sector, the portfolio is most concentrated in Technology at 3.1% of assets, down from 3.2% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $622M trimmed.

  • Ken Griffin's largest Q3 2021 buy was Etsy: 948,509 shares worth $197M.
  • Ken Griffin added most to Tesla in Q3 2021, an estimated $1.26B increase.
  • Ken Griffin's biggest Q3 2021 reduction was Meta Platforms (Facebook), cutting an estimated $622M.
  • Ken Griffin fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $597M.
  • Ken Griffin's ten largest holdings make up 29% of its $481B portfolio in Q3 2021.
  • Ken Griffin opened 1,885 new positions and closed 1,724 in Q3 2021.
  • Ken Griffin's portfolio value rose 7.8% quarter-over-quarter to $481B.

Based on Citadel Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.